1. Zhao H, Xu R, Ouyang Q, Chen L, Dong B, Huihua Y. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions. Eur J Radiol. 2010; 73:288–293. PMID:
19559551.
Article
2. Ricci P, Cantisani V, Ballesio L, Pagliara E, Sallusti E, Drudi FM, et al. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging. Ultraschall Med. 2007; 28:57–62. PMID:
17304413.
Article
3. Du J, Li FH, Fang H, Xia JG, Zhu CX. Microvascular architecture of breast lesions: evaluation with contrast-enhanced ultrasonographic micro flow imaging. J Ultrasound Med. 2008; 27:833–842. PMID:
18499843.
4. Jiang YX, Liu H, Liu JB, Zhu QL, Sun Q, Chang XY. Breast tumor size assessment: comparison of conventional ultrasound and contrast-enhanced ultrasound. Ultrasound Med Biol. 2007; 33:1873–1881. PMID:
17686569.
Article
5. Saracco A, Aspelin P, Leifland K, Themudo R, Wilczek B, Axelsson R. Bolus compared with continuous infusion of microbubble contrast agent using real-time contrast harmonic imaging ultrasound in breast tumors. Acta Radiol. 2009; 50:854–859. PMID:
19634024.
Article
6. Sorelli PG, Cosgrove DO, Svensson WE, Zaman N, Satchithananda K, Barrett NK, et al. Can contrast-enhanced sonography distinguish benign from malignant breast masses? J Clin Ultrasound. 2010; 38:177–181. PMID:
20146214.
Article
7. Barnard S, Leen E, Cooke T, Angerson W. A contrast-enhanced ultrasound study of benign and malignant breast tissue. S Afr Med J. 2008; 98:386–391. PMID:
18637311.
8. Kettenbach J, Helbich TH, Huber S, Zuna I, Dock W. Computer-assisted quantitative assessment of power Doppler US: effects of microbubble contrast agent in the differentiation of breast tumors. Eur J Radiol. 2005; 53:238–244. PMID:
15664287.
Article
9. Guo L, Liu ZG, Han PH, Yuan Q, He Y, Li J. Perfusion curve f (t) analysis of breast cancer by contrast-enhanced ultrasonography. Acta Radiol. 2012; 53:981–986. PMID:
22969089.
Article
10. Anaye A, Perrenoud G, Rognin N, Arditi M, Mercier L, Frinking P, et al. Differentiation of focal liver lesions: usefulness of parametric imaging with contrast-enhanced US. Radiology. 2011; 261:300–310. PMID:
21746815.
Article
11. Li YJ, Wen G, Wu FL. Study on the regional hemodynamic perfusion characteristics in benign and malignant breast tumors by contrast-enhanced ultrasound quantitative analysis. Biomed Eng Clin Med. 2009; 13:431–435.
12. Balleyguier C, Opolon P, Mathieu MC, Athanasiou A, Garbay JR, Delaloge S, et al. New potential and applications of contrast-enhanced ultrasound of the breast: own investigations and review of the literature. Eur J Radiol. 2009; 69:14–23. PMID:
18977102.
Article
13. Liu H, Jiang YX, Liu JB, Zhu QL, Sun Q. Evaluation of breast lesions with contrast-enhanced ultrasound using the microvascular imaging technique: initial observations. Breast. 2008; 17:532–539. PMID:
18534851.
Article
14. van Esser S, Veldhuis WB, van Hillegersberg R, van Diest PJ, Stapper G, ElOuamari M, et al. Accuracy of contrast-enhanced breast ultrasound for pre-operative tumor size assessment in patients diagnosed with invasive ductal carcinoma of the breast. Cancer Imaging. 2007; 7:63–68. PMID:
17513187.
Article
15. Caproni N, Marchisio F, Pecchi A, Canossi B, Battista R, D'Alimonte P, et al. Contrast-enhanced ultrasound in the characterisation of breast masses: utility of quantitative analysis in comparison with MRI. Eur Radiol. 2010; 20:1384–1395. PMID:
20033178.
Article
16. Li SP, Padhani AR, Taylor NJ, Beresford MJ, Ah-See ML, Stirling JJ, et al. Vascular characterisation of triple negative breast carcinomas using dynamic MRI. Eur Radiol. 2011; 21:1364–1373. PMID:
21258931.
Article
17. Makkat S, Luypaert R, Sourbron S, Stadnik T, De Mey J. Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data. J Magn Reson Imaging. 2007; 25:1159–1167. PMID:
17520720.
Article